Psyence Biomedical Ltd.
Psyence Biomedical Ltd. (PBM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PBM · as of Jun 8, 2026
Key Statistics
Explore Psyence Biomedical Ltd. Data
pbm stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
pbm competitorsPBM
AZTR
DRMA
ELAB
GTBP
INDPStock Performance
Full HistoryAbout Psyence Biomedical Ltd.
Psyence Biomedical Ltd. is dedicated to advancing psychedelic medicines formulated from botanical psilocybin. The firm is actively exploring natural psilocybin as a potential therapy for adjustment di…
what is psyence biomedical ltd. · pbm stock overview · psyence biomedical ltd. company profile · who is psyence biomedical ltd. ceo · pbm NASDAQ · psyence biomedical ltd. headquarters · psyence biomedical ltd. business segments
About Stock Overview & Key Data
Psyence Biomedical Ltd. (PBM) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 10, 2021. As of the latest trading session, PBM stock price is $3.61, with a market capitalization of $68,468. The stock has returned -88.89% over the past 12 months and -23.73% year-to-date.
In fiscal year 2025, Psyence Biomedical Ltd. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Psyence Biomedical Ltd. (PBM) stock price is $3.61. The stock is traded on NASDAQ under the ticker symbol PBM. The 52-week range is $1.92 – $468.36.